Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 北京天坛生物制品股份有限公司是目前我国最大的生物制品研究和生产基地之一,是央企中国生物技术集团公司下辖的唯一的一家上市公司.公司主要从事疫苗、血液制剂、诊断用品等生物制品的研发、生产和销售,主导产品包括重组酵母乙型肝炎疫苗、风疹活疫苗、骨髓灰质炎疫苗、乙型脑炎灭活疫苗、麻风二联疫苗(MR)、各种诊断试剂等20多个品种,主营产品占有国内50%以上的市场份额.公司全部生产车间已通过了国家食品药品监督管理局(SFDA)的GMP认证,主要生产车间已达到国际先进水平.公司生产的H1N1流感疫苗获国家收储。 | ||||||||||||||||||||||||
Main Business | 血液制品的研发、生产和销售。 | ||||||||||||||||||||||||
Legal Representative | 付道兴 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 张翼 | ||||||||||||||||||||||||
Solicitors | 北京市嘉源律师事务所 | ||||||||||||||||||||||||
Auditors | 天健会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 010-65439720 | ||||||||||||||||||||||||
Fax No | 010-65436770 | ||||||||||||||||||||||||
Website | www.TiantanBio.com | ||||||||||||||||||||||||
ttsw@sinopharm.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 16/06/1998 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.670 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.150 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 5.961 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 41.070B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |